BOSTON – April 11, 2019 – David J. Dykeman, patent attorney and co-chair of Greenberg Traurig, LLP’s global Life Sciences & Medical Technology Group and Boston Intellectual Property & Technology (IP) Group, organized the Lifesciences L’chaim Networking Event hosted by Combined Jewish Philanthropies (CJP) held April 4. He led a panel discussion on the latest trends in the life sciences and medical technology industries. Dykeman was a member of the event host committee, and Greenberg Traurig was an event sponsor.
The CJP event brought together senior executives, entrepreneurs, and investors from across the biotech, pharma, healthcare, medtech and diagnostics industries to strengthen business relationships within the Greater Boston Jewish community. Members of the Lifesciences L'chaim event host committee include:
- Alan Crane, Polaris Partners
- David Dykeman, Greenberg Traurig, LLP
- Eli Goldberg, Novartis
- Luba Greenwood, Google Life Sciences
- Jeff Karp, Brigham and Women’s Hospital
- Geoff Meyerson, Locust Walk
- Michal Preminger, Johnson & Johnson Innovation
- Ilonna Rimm, Morninglight Healthcare Capital
About Greenberg Traurig’s Life Sciences & Medical Technology Group: Greenberg Traurig’s Life Sciences & Medical Technology Group advises clients ranging from start-ups to large multinational public companies to leading research institutions. The group’s attorneys work closely with clients, providing innovative legal counsel to help them achieve their objectives – from discovery through commercialization and product marketing.
About Greenberg Traurig: Greenberg Traurig, LLP (GT) has more than 2,000 attorneys in 39 offices in the United States, Latin America, Europe, Asia, and the Middle East. GT has been recognized for its philanthropic giving, diversity, and innovation, and is consistently among the largest firms in the U.S. on the Law360 400 and among the Top 20 on the Am Law Global 100. Web: http://www.gtlaw.com Twitter: @GT_Law